The well-known inflammatory marker IL-6 has also been positively associated with AAA prevalence, and showed potential as a diagnostic marker in this study population (AUC (95% CI); 0.73 (0.67–0.79), sensitivity = 80% and specificity = 49%) (Fig. 5) [35]. The gene discussed is IL6; the disease is triple-A syndrome.